Gut dysbiosis: Ecological causes and causative effects on human disease

被引:31
|
作者
Winter, Sebastian E. [1 ,2 ]
Baeumler, Andreas J. [2 ]
机构
[1] Univ Calif Davis, Dept Med, Div Infect Dis, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA
关键词
microbiota; dysbiosis; colitis; colorectal cancer; CHAIN FATTY-ACIDS; ENTERICA SEROVAR TYPHIMURIUM; ACTIVATED-RECEPTOR-GAMMA; INTESTINAL MICROBIOTA; NITRIC-OXIDE; ESCHERICHIA-COLI; SALMONELLA INFECTION; ENHANCED SUSCEPTIBILITY; NITRATE RESPIRATION; ENERGY-METABOLISM;
D O I
10.1073/pnas.2316579120
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The gut microbiota plays a role in many human diseases, but high- throughput sequence analysis does not provide a straightforward path for defining healthy microbial communities. Therefore, understanding mechanisms that drive compositional changes during disease (gut dysbiosis) continues to be a central goal in microbiome research. Insights from the microbial pathogenesis field show that an ecological cause for gut dysbiosis is an increased availability of host- derived respiratory electron acceptors, which are dominant drivers of microbial community composition. Similar changes in the host environment also drive gut dysbiosis in several chronic human illnesses, and a better understanding of the underlying mechanisms informs approaches to causatively link compositional changes in the gut microbiota to an exacerbation of symptoms. The emerging picture suggests that homeostasis is maintained by host functions that control the availability of resources governing microbial growth. Defining dysbiosis as a weakening of these host functions directs attention to the underlying cause and identifies potential targets for therapeutic intervention.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Gut dysbiosis mediates the association between antibiotic exposure and chronic disease
    Guarner, Francisco
    Fernandez, Luis Bustos
    Cruchet, Sylvia
    Damiao, Aderson
    Saito, Aldo Maruy
    Lopez, Juan Pablo Riveros
    Silva, Luciana Rodrigues
    Diaz, Miguel Angel Valdovinos
    FRONTIERS IN MEDICINE, 2024, 11
  • [32] Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
    Pisani, Anthea
    Rausch, Philipp
    Bang, Corinna
    Ellul, Sarah
    Tabone, Trevor
    Cordina, Claire Marantidis
    Zahra, Graziella
    Franke, Andre
    Ellul, Pierre
    MICROBIOLOGY SPECTRUM, 2022, 10 (03):
  • [33] IUPHAR review: From gut to brain: The role of gut dysbiosis, bacterial amyloids, and metabolic disease in Alzheimer's disease
    Inan, Saadet
    Wilson, R. Paul
    Tukel, Cagla
    PHARMACOLOGICAL RESEARCH, 2025, 215
  • [34] Understanding dysbiosis and resilience in the human gut microbiome: biomarkers, interventions, and challenges
    Safarchi, Azadeh
    Al-Qadami, Ghanyah
    Tran, Cuong D.
    Conlon, Michael
    FRONTIERS IN MICROBIOLOGY, 2025, 16
  • [35] Gut-brain axis: gut dysbiosis and psychiatric disorders in Alzheimer's and Parkinson's disease
    Denman, Charlotte R.
    Park, Sang Myun
    Jo, Junghyun
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [36] Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis
    Chaves, Lee D.
    McSkimming, Daniel, I
    Bryniarski, Mark A.
    Honan, Amanda M.
    Abyad, Sham
    Thomas, Shruthi A.
    Wells, Steven
    Buck, Michael
    Sun, Yijun
    Genco, Robert J.
    Quigg, Richard J.
    Yacoub, Rabi
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 315 (03) : F487 - F502
  • [37] Dysbiosis, obesity, and inflammation: interrelated phenomena causes or effects of metabolic syndrome?
    Wani, Kaiser
    Rahman, Shakilur
    Draz, Hossam
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [38] Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease
    Teramoto, Yoshiki
    Akagawa, Shohei
    Hori, Shin-ichiro
    Tsuji, Shoji
    Higasa, Koichiro
    Kaneko, Kazunari
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [39] Gut dysbiosis in alcoholic liver disease: Wonderful dilemma?
    Abenavoli, Ludovico
    Scarpellini, Emidio
    ANNALS OF HEPATOLOGY, 2023, 28 (05)
  • [40] Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson's Disease from India
    Pavan, Sujith
    Gorthi, Sankar Prasad
    Prabhu, Arvind N.
    Das, Bhabatosh
    Mutreja, Ankur
    Vasudevan, Karthick
    Shetty, Vignesh
    Ramamurthy, Thandavarayan
    Ballal, Mamatha
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2023, 26 (06) : 908 - +